Delivery Order SPE2DB24D2003-SPE2DB24FXFC9

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,929.26, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The contract has a firm fixed-price pricing type and an ultimate completion date of January 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,507.44, is for the delivery of 4560843381 - Telmisartan-HCTZ 80-12.5 mg tablets in units of 30s. The contract has a firm fixed price and has a completion date of May 8, 2023. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in units of 30, with a total ceiling value of $1,197.12. It is a Firm Fixed Price Delivery Order contract with a completion date of June 13, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in 30-count units, with a ceiling value of $1,745.72. It is a firm fixed-price delivery order contract with a completion date of June 5, 2025. The contract is not set-aside and is open for competition. AmerisourceBergen Drug Corp also holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,851.03, is for the provision of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count unit doses. The award was made on January 7, 2025, with an ultimate completion date of January 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count packages, with a ceiling value of $4,434.96 and a period of performance through May 6, 2025. The contract is not set aside and is considered an open competition award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan-HCTZ 80-25 mg tablets. The contract has a ceiling value of $9,207.44 and a completion date of July 15, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $1,151.76 and is a Delivery Order contract for the provision of Telmisartan-HCTZ 80-12.5 mg tablets. The contract does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,926.81, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets. It has an ultimate completion date of March 6, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,553.64, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract is a firm fixed-price delivery order, with a period of performance through May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
  • SPE2DB24D2003
    Indefinite Delivery Contract
  • SPE2DB24D2003-SPE2DB24FXFC9
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units, with a ceiling value of $6,560.81 and a completion date of June 21, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:10 AM